| Authors: |
Dul M; Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK., Alali M; World Health Organization, Geneva, Switzerland., Ameri M; Americeutics Consulting, USA; previously Zosano Pharma, USA., Burke MD; Stemline Therapeutics Inc, a Menarini Group Company, USA; previously Radius Health, Inc., USA., Creelman BP; PATH, Seattle, USA., Dick L; Previously Kindeva Drug Delivery, USA., Donnelly RF; School of Pharmacy, Queen's University Belfast, Belfast, UK., Eakins MN; Eakins & Associates, USA., Frivold C; PATH, Seattle, USA., Forster AH; Vaxxas Pty Ltd, Australia., Gilbert PA; Bill & Melinda Gates Foundation, Seattle, USA., Henke S; Bioaxxent - Drug Delivery, Germany; previously LTS Lohmann Therapie-Systeme AG, Germany., Henry S; Micron Biomedical, Inc., USA., Hunt D; United States Pharmacopeia, USA., Lewis H; Previously Zosano Pharma, USA., Mistilis JJ; PATH, Seattle, USA., Park JH; Department of Bionano Technology, Gachon University, Seongnam, Republic of Korea., Prausnitz MR; School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA, USA., Robinson DK; Bill & Melinda Gates Foundation, Seattle, USA., Hernandez CAR; World Health Organization, Geneva, Switzerland., Shin J; Raphas Co. Ltd, Republic of Korea., Speaker TJ; AbbVie Inc, USA., Strasinger C; Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration (FDA), USA., Taylor KMG; University College London School of Pharmacy, UK; previously British Pharmacopoeia Commission, UK., Zehrung D; Zehrung Global Health LLC, USA., Birchall JC; Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK., Jarrahian C; PATH, Seattle, USA., Coulman SA; Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK. Electronic address: coulmansa@cardiff.ac.uk. |
